We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Liquid-Ready QC Solution for POC Urinalysis Instruments Helps Labs Streamline Daily Operations

By LabMedica International staff writers
Posted on 23 Jan 2023

Healthcare and laboratory professionals need to ensure consistent and accurate results. More...

Now, a liquid-ready urinalysis solution for use with point-of-care urinalysis instruments and reagents, including 12 parameters and hCG, aims to help labs streamline their daily operations.

Siemens Healthineers (Erlangen, Germany) has launched Chek-Stix Liquid Quality Control solutions - the latest innovation in its urinalysis portfolio. Chek-Stix UA Diptube Liquid QC contains both Level 1 (negative for all chemistry parameters and positive for hCG) and Level 2 (positive for all chemistry parameters and negative for hCG), packaged in one box. Both Level 1 and Level 2 diptube controls are ready-to-use liquid quality controls for use with the CLINITEK Status+ Analyzer, CLINITEK Advantus Analyzer, and visual-read urine strips.

Liquid-ready solution means less time spent on prepping quality control solution and more time on running patient samples. The product is barcode-enabled for quick, accurate data input and supports Siemens’ broad urine chemistry parameter menu. Validated for use with all Siemens’ urinalysis devices and reagents, the product has a shelf life of 22 months from the manufacture date.

Related Links:
Siemens Healthineers


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: USU chemists Kadin Crosby, Bamidele Filani, and Ryan Jackson have reported newly discovered functions of CRISPR-Cas12a3 (Photo courtesy of USU/M. Muffoletto)

CRISPR Discovery Paves Way for Single Diagnostic Test for COVID, Flu and RSV

Immune systems across all forms of life defend against viruses by blocking their ability to replicate. Many CRISPR-based defenses achieve this by cutting viral DNA, but these approaches can damage host... Read more

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.